Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective study

Acute graft versus host disease (aGVHD) remains a major problem after allogeneic hematopoietic stem cell transplantation. Standard frontline therapy for aGVHD involves corticosteroids. However, fewer than half of patients have a lasting complete response. The long-term mortality rate of steroid-refr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Tan, Yamin, Xiao, Haowen, Wu, Depei, Luo, Yi, Lan, Jianping, Liu, Qifa, Yu, Kang, Shi, Jimin, He, Jingsong, Zheng, Weiyan, Lai, Xiaoyu, Zhu, Yuanyuan, Du, Kaili, Ye, Yishan, Zhao, Yanmin, Zheng, Gaofeng, Hu, Yongxian, Han, Xiaoyan, Zheng, Yanlong, Wei, Guoqing, Cai, Zhen, Huang, He
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5384382/
https://ncbi.nlm.nih.gov/pubmed/28405499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1277307
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados